Partner Headlines - LLY

  1. Southern Company Leads 52 Stocks Going Ex-Dividend Next Week

    Dividend.com
  2. Biogen Stock Pops As Merck, Allergan Reportedly Probing Buyout

    Investors Business Daily
  3. AbbVie, Merck Beat Earnings Estimates, But Sanofi Lags

    Investors Business Daily
  4. Alder Biopharma Migraine Drug Holds Up After 6 Months

    Investors Business Daily
  5. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings ...

    Investors Business Daily
  6. Top Funds Heart Edward Lifesciences, Bump Lilly

    IBD
  7. Merck Stock Slides As Q4 Revenue, Guidance Miss Expectations

    IBD
  8. Earnings Recap For January 28

    Benzinga
  9. Eli Lilly Punished For Inline Report

    Benzinga
  10. JNJ Kicks Off Health Care Earnings—What About Deals, Buybacks?

    Benzinga
  11. Stock Marquee Crowded With Oil, Apple, and the Fed

    Benzinga
  12. Last-Hour Rally Erases Midday Losses As Indexes Close Mixed

    IBD
  13. Steven Cohen Makes Eli Lilly, Kraft Heinz Top New Buys

    GuruFocus
  14. A Calmer Year For Pharma?

    IBD
  15. 3 Potential Blockbuster Drugs Launching in 2016

    IBD
  16. Lilly Counts On Pipeline In '16

    IBD
  17. Lilly Guidance Misses Estimates On Lower Sales

    IBD
  18. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD
  19. 5 Top Stocks of the Outperforming Vanguard Health Care Fund

    GuruFocus
  20. Mairs and Power Sells Baxalta, Walt Disney, Target

    GuruFocus
  21. Strategic Beta ETFs Among Year's Top Performers

    IBD
  22. Benzinga's Top Upgrades

    Benzinga
  23. GoPro PT Cut; Chipotle, Bluebird Bio Downgraded

    IBD
  24. Cautious Stock Rebound as Jobs Data Delivers But Wages Still ...

    Benzinga
  25. Lilly Ends Basal Insulin Peglispro Development Program

    Benzinga
  26. HOTCHKIS & WILEY Buys More Than 7 Million Shares in Oil and Gas ...

    GuruFocus
  27. Merck

    IBD
  28. 3 Big Pharma Upgrades (And One Downgrade) At Barclays

    IBD
  29. Amazon's PT Raised; Yum, J&J, Merck, Lilly Upgraded

    IBD
  30. Benzinga's Top Upgrades

    Benzinga
  31. Sanofi Chipping Away At Biogen's MS Dominance

    IBD
  32. Steven Cohen Hikes Stake in Microsoft by More Than 50,000%

    GuruFocus
  33. Biotechs Weaken, But These Names Have Bullish Charts

    IBD
  34. Eli Lilly Release Confirms FDA Approval If Portrazza

    Benzinga
  35. Lilly and Merck Expand Immuno-oncology Collaboration with Phase ...

    Benzinga
  36. Goldman Sachs' Top 4 Smid-Cap Biotech Picks

    IBD
  37. PRIMECAP Sells Stake in Technology Company

    GuruFocus
  38. Benzinga's Top Upgrades

    Benzinga
  39. ELI LILLY

    IBD
  40. Lilly, Incyte Announce Data Demonstrate Baricitinib Superiority ...

    Benzinga
  41. DOJ Eyes Lilly, Merck Pricing

    IBD
  42. How This Top Stock Mutual Fund Manager Seeks Growth

    IBD
  43. How This Top Stock Mutual Fund Manager Seeks Growth

    IBD
  44. Sanofi, Novo Nordisk Slide On Diabetes Headwinds

    IBD
  45. Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase ...

    Benzinga
  46. Eli Lilly Q3 Earnings, Guidance Beat On Cost Control

    IBD
  47. Eli Lilly CEO: Our Drug Prices are Fair

    FoxBusiness
  48. McDonald's Strong 3Q Helps Wall Street Jump

    FoxBusiness
  49. Eli Lilly Posts Upbeat Q3 Earnings, Raises Forecast

    Benzinga
  50. Eli Lilly Reports Mixed 3Q Results

    FoxBusiness
  51. Lilly supports global Dementia Discovery Fund

    Benzinga
  52. Wal-Mart's $21 Billion Loss Lost on NYSE Officials

    FoxBusiness
  53. Lilly-Incyte drug beats Humira

    IBD
  54. Lilly-Incyte Drug Beats Humira In Arthritis Trial

    IBD
  55. US Stock Futures Down; JPMorgan Earnings In Focus

    Benzinga
  56. Lilly and ImaginAb Announce Preclinical Immuno-Oncology Collaboration, ...

    Benzinga
  57. Fast Money Traders Share Their Thoughts On Eli Lilly and And ...

    Benzinga
  58. Eli Lilly Pulls Cholesterol Drug

    IBD
  59. Indexes Close Up Across The Board; Facebook Gains, But Twitter ...

    IBD
  60. Stocks Near Flatline; Bad News for Lilly Is Good News For Regeneron

    IBD
  61. Regeneron Stock Pops But Hits Resistance At 50-Day

    IBD
  62. Lilly Kills 'High Risk/High Reward' Cholesterol Drug

    IBD
  63. Stocks Poised For Modestly Higher Start; EMC Jumps In Premarket

    IBD
  64. US Stock Futures Flat Ahead Of Fed Speakers

    Benzinga
  65. Lilly, Innovent Biologics Expand Their Strategic Alliance

    Benzinga
  66. Eli Lilly

    IBD
  67. Lilly Upgraded On Bullish Diabetes Outlook

    IBD
  68. Benzinga's Top Upgrades

    Benzinga
  69. Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib ...

    Benzinga
  70. A Cholesterol Drug Revolution

    IBD
  71. Are Cholesterol Drugs In For Another Revolution?

    IBD
  72. Morning Market Losers

    Benzinga
  73. Despite EU OK, Regeneron Crumbles Below 200-Day

    IBD
  74. Lilly's CYRAMZA® (ramucirumab) Significantly Improves Progression-Free ...

    Benzinga
  75. AbbVie Spurns Galapagos To Advance Own Arthritis Drug

    IBD
  76. Forget The 2016 Election Candidates, CEOs Are Driving Change

    Benzinga
  77. Lilly's New Diabetes Drug Delivers "One of a Kind" Results

    FoxBusiness
  78. Benzinga's Top Initiations

    Benzinga
  79. U.S. District Court Rules in Lilly's Favor on Alimta Vitamin ...

    Benzinga
  80. Benzinga's Volume Movers

    Benzinga
  81. Lilly Issues Update on Evacetrapib Phase 3 Trial: Last Patient ...

    Benzinga
  82. Biogen's Big-Volume Plunge Marks End Of 5-Year Run

    IBD
  83. Valeant Posts Princely Gains

    IBD
  84. 3 Big-Cap Drugmakers Who Beat Q2 Earnings Estimates

    IBD
  85. Shire Lifts 2015 Guidance On Strong Drug Pipeline

    IBD
  86. Lilly, Bristol-Myers Beat Q2 Views, Lift Guidance

    IBD
  87. Valeant Earnings Soar On M&A, Organic Sales Growth

    IBD
  88. Wall Street Struggles for Direction After Two-Day Selloff

    FoxBusiness
  89. Alzheimer's Data Diverge

    IBD
  90. Biogen, Lilly Alzheimer's Data Spark Street Debate

    IBD
  91. Are We Any Closer to Finding a Drug to Battle Alzheimer's?

    FoxBusiness
  92. Data Using New Delayed-Start Methodology Suggested Benefit of ...

    Benzinga
  93. Fast Money Picks For July 21

    Benzinga
  94. 6 Big-Cap Drugmakers Reporting Earnings Next Week

    IBD
  95. Celgene Hits High As Street Applauds Receptos Buyout

    IBD
  96. Manning & Napier Advisors' Most Weighted Trades in Q2 2015

    GuruFocus
  97. Weekly 52-Week Highs Highlight: LLY, PLL, SBUX, VLO

    GuruFocus
  98. Eli Lilly Shares Go Parabolic

    Benzinga
  99. Stocks Cling To Thin Early Gains; Ambarella Bounces, Cree Dives

    IBD
  100. Alder Bio Up As Credit Suisse Lauds Migraine Drug

    IBD
Trading Center